key: cord-0078158-kaw3oz0q
authors: Hussein, Nawfal R
title: The Mediterranean Journal of Hematology and Infectious Diseases: A New Milestone and a Hope for Researchers in Third World Countries
date: 2022-05-01
journal: Mediterr J Hematol Infect Dis
DOI: 10.4084/mjhid.2022.035
sha: fbc9bdfeb656e7991a84dea342f3663905974742
doc_id: 78158
cord_uid: kaw3oz0q

nan

We learned with pleasure that The Mediterranean Journal of Hematology and Infectious Diseases had hit a new milestone by obtaining an impact factor of 2.576. We want to congratulate you on this achievement. From our point of view, in a country with poor resources and enthusiastic researchers, the MJHID was a shelter for our papers. This Journal provides three advantages for us. Firstly, English language weakness does not influence the decision, and secondly, it provides a good guide to the researcher to build a good quality project. Thirdly, the communication with the Editor is straightforward without obstacles. Utilizing such advantages, we could have published good papers in the MJHID, gaining readers' attention and recording good citations. [1] [2] [3] [4] [5] It is believed that the advantages the MJHID provided to authors have played a role in hitting such a milestone. The new Journal's achievement should not change its standards to continue encouraging us all the researchers of lowincome countries. Therefore, we believe that hitting a new milestone should drive you to increase the help to researchers in the low-income research setting and where the research resources are sparse. We suggest the Journal establish a mentoring committee to help such researchers meet international standards and make necessary amendments to the projects rather than rejecting the papers in the first screening and/or revision round. Finally, in a world full of challenges for researchers who work in an environment that does not appreciate and support research, we hope to support and provide a platform that makes our voice heard. Nawfal R Hussein.

The Department of Biomedical Sciences, The College of Medicine, University of Zakho, Kurdistan Region of Iraq.

The efficacy and safety of sofosbuvir-containing regimen in the treatment of HCV infection in patients with haemoglobinopathy

A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region

The efficacy and safety of intralesional sodium stibogluconate for the treatment of cutaneous Leishmaniasis in children under the age of two years

The risk of SARS-CoV-2 reinfection in Duhok city, Kurdistan region of Iraq

Direct acting antiviral treatment for patients with end-stage kidney disease with acute HCV infection